254 related articles for article (PubMed ID: 15841490)
21. SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9.
Simarro M; Lanyi A; Howie D; Poy F; Bruggeman J; Choi M; Sumegi J; Eck MJ; Terhorst C
Int Immunol; 2004 May; 16(5):727-36. PubMed ID: 15096483
[TBL] [Abstract][Full Text] [Related]
22. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
[TBL] [Abstract][Full Text] [Related]
23. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
Howie D; Sayos J; Terhorst C; Morra M
Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
[TBL] [Abstract][Full Text] [Related]
24. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.
Hare NJ; Ma CS; Alvaro F; Nichols KE; Tangye SG
Int Immunol; 2006 Jul; 18(7):1055-65. PubMed ID: 16720617
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
26. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
Kis LL; Nagy N; Klein G; Klein E
Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
[TBL] [Abstract][Full Text] [Related]
27. X-linked lymphoproliferative disease: a progressive immunodeficiency.
Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
[TBL] [Abstract][Full Text] [Related]
28. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
[TBL] [Abstract][Full Text] [Related]
29. XLP: one gene, many players.
Czar MJ; Schwartzberg PL
Clin Immunol; 2001 Jul; 100(1):2-3. PubMed ID: 11414739
[No Abstract] [Full Text] [Related]
30. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.
Morra M; Lu J; Poy F; Martin M; Sayos J; Calpe S; Gullo C; Howie D; Rietdijk S; Thompson A; Coyle AJ; Denny C; Yaffe MB; Engel P; Eck MJ; Terhorst C
EMBO J; 2001 Nov; 20(21):5840-52. PubMed ID: 11689425
[TBL] [Abstract][Full Text] [Related]
32. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
[TBL] [Abstract][Full Text] [Related]
33. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.
Coffey AJ; Brooksbank RA; Brandau O; Oohashi T; Howell GR; Bye JM; Cahn AP; Durham J; Heath P; Wray P; Pavitt R; Wilkinson J; Leversha M; Huckle E; Shaw-Smith CJ; Dunham A; Rhodes S; Schuster V; Porta G; Yin L; Serafini P; Sylla B; Zollo M; Franco B; Bolino A; Seri M; Lanyi A; Davis JR; Webster D; Harris A; Lenoir G; de St Basile G; Jones A; Behloradsky BH; Achatz H; Murken J; Fassler R; Sumegi J; Romeo G; Vaudin M; Ross MT; Meindl A; Bentley DR
Nat Genet; 1998 Oct; 20(2):129-35. PubMed ID: 9771704
[TBL] [Abstract][Full Text] [Related]
34. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
[No Abstract] [Full Text] [Related]
35. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.
Fraser CC; Howie D; Morra M; Qiu Y; Murphy C; Shen Q; Gutierrez-Ramos JC; Coyle A; Kingsbury GA; Terhorst C
Immunogenetics; 2002 Feb; 53(10-11):843-50. PubMed ID: 11862385
[TBL] [Abstract][Full Text] [Related]
36. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.
Sayós J; Martín M; Chen A; Simarro M; Howie D; Morra M; Engel P; Terhorst C
Blood; 2001 Jun; 97(12):3867-74. PubMed ID: 11389028
[TBL] [Abstract][Full Text] [Related]
37. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
Engel P; Eck MJ; Terhorst C
Nat Rev Immunol; 2003 Oct; 3(10):813-21. PubMed ID: 14523387
[TBL] [Abstract][Full Text] [Related]
38. Fine-tuning of immune responses by SLAM-related receptors.
Bhat R; Eissmann P; Endt J; Hoffmann S; Watzl C
J Leukoc Biol; 2006 Mar; 79(3):417-24. PubMed ID: 16365151
[TBL] [Abstract][Full Text] [Related]
39. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
40. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
